21 May 2009
The lipid profile of the living kidney donors
M Bieniasz, A Kwiatkowski, J Gozdowska, R Kieszek, P Domagała, A Darocha, J Trzebicki, M Durlik, L Pączek, A ChmuraAnn Transplant 2009; 14(1): 50-50 :: ID: 880383
Abstract
Background: Living kidney donation is becoming more significant as the
number of cadaveric transplants remains fairly constant and outcome does
not improve due to accumulation of aged patients with a long time on dialysis. Only 2-3% of kidney transplants in Poland come from the living donors. Lipid profiles of the living donors need to be evaluated in order to stratify cardiovascular risk before donation. The aim of this study was to assess the lipid profile of living kidney donors.
Material/Methods: Between 1995 and 2005, 66 living donor open nephrectomies were performed. Physical examination, blood and urine tests were performed prior to nephrectomy and at every follow-up visit (36 months and every 12 months post-op). Donor mean age was 40.9 years (range 29-60). There were 21 women and 18 men. 27 donors did not report for follow-up visits. Observation period ranged from 36 to 156 months. Hypercholesterolemia was defined as total cholesterol concentration >200 mg/dl. Hypertrigyceridemia was defined as triglycerides concentration 150 mg/dl.
Results: Hyperlipidaemia was present in 3 (7.7%) donors prior to surgery.
22 (56.4%) patients developed hyperlipidaemia after donation. Appropriate
treatment was initiated for hyperlipidaemia in the diagnosed patients. 15 patients had mild hyperlipidaemia treated by diet modification and 7 patients needed statin administration. No cases of diabetes mellitus were observed.
Conclusions: Follow-up of living kidney donors' lipid profile should be included in the work-up as prevention of cardiovascular disease.
Keywords: Kidney Transplantation, Living Donors
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860